Literature DB >> 30446383

RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs.

Bing Wu1, Song Zhang1, Zengli Guo1, Gang Wang2, Ge Zhang3, Ling Xie4, Jitong Lou5, Xian Chen4, Di Wu6, Wolfgang Bergmeier7, Junnian Zheng8, Yisong Y Wan9.   

Abstract

Pathogenic Th17 (pTh17) cells drive inflammation and immune-pathology, but whether pTh17 cells are a Th17 cell subset whose generation is under specific molecular control remains unaddressed. We found that Ras p21 protein activator 3 (RASA3) was highly expressed by pTh17 cells relative to non-pTh17 cells and was required specifically for pTh17 generation in vitro and in vivo. Mice conditionally deficient for Rasa3 in T cells showed less pathology during experimental autoimmune encephalomyelitis. Rasa3-deficient T cells acquired a Th2 cell-biased program that dominantly trans-suppressed pTh17 cell generation via interleukin 4 production. The Th2 cell bias of Rasa3-deficient T cells was due to aberrantly elevated transcription factor IRF4 expression. RASA3 promoted proteasome-mediated IRF4 protein degradation by facilitating interaction of IRF4 with E3-ubiquitin ligase Cbl-b. Therefore, a RASA3-IRF4-Cbl-b pathway specifically directs pTh17 cell generation by balancing reciprocal Th17-Th2 cell programs. These findings indicate that a distinct molecular program directs pTh17 cell generation and reveals targets for treating pTh17 cell-related pathology and diseases.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cbl-b; EAE disease; IL-4; IRF4; RASA3; pathogenic Th17 cell; pathogenic Th17-Th2 reciprocal programs

Mesh:

Substances:

Year:  2018        PMID: 30446383      PMCID: PMC6249088          DOI: 10.1016/j.immuni.2018.09.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  56 in total

Review 1.  Regulatory T cells: key controllers of immunologic self-tolerance.

Authors:  S Sakaguchi
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

2.  The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4.

Authors:  Anne Brüstle; Sylvia Heink; Magdalena Huber; Christine Rosenplänter; Christine Stadelmann; Philipp Yu; Enrico Arpaia; Tak W Mak; Thomas Kamradt; Michael Lohoff
Journal:  Nat Immunol       Date:  2007-08-05       Impact factor: 25.606

Review 3.  TH17 cells in development: an updated view of their molecular identity and genetic programming.

Authors:  Chen Dong
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

4.  TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma.

Authors:  David F Choy; Kevin M Hart; Lee A Borthwick; Aarti Shikotra; Deepti R Nagarkar; Salman Siddiqui; Guiquan Jia; Chandra M Ohri; Emma Doran; Kevin M Vannella; Claire A Butler; Beverley Hargadon; Joshua C Sciurba; Richard L Gieseck; Robert W Thompson; Sandra White; Alexander R Abbas; Janet Jackman; Lawren C Wu; Jackson G Egen; Liam G Heaney; Thirumalai R Ramalingam; Joseph R Arron; Thomas A Wynn; Peter Bradding
Journal:  Sci Transl Med       Date:  2015-08-19       Impact factor: 17.956

Review 5.  The Ras/Rap GTPase activating protein RASA3: from gene structure to in vivo functions.

Authors:  Stéphane Schurmans; Séléna Polizzi; Ariane Scoumanne; Sufyan Sayyed; Patricia Molina-Ortiz
Journal:  Adv Biol Regul       Date:  2014-09-28

6.  RASA3 is a critical inhibitor of RAP1-dependent platelet activation.

Authors:  Lucia Stefanini; David S Paul; Raymond F Robledo; E Ricky Chan; Todd M Getz; Robert A Campbell; Daniel O Kechele; Caterina Casari; Raymond Piatt; Kathleen M Caron; Nigel Mackman; Andrew S Weyrich; Matthew C Parrott; Yacine Boulaftali; Mark D Adams; Luanne L Peters; Wolfgang Bergmeier
Journal:  J Clin Invest       Date:  2015-02-23       Impact factor: 14.808

7.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

8.  Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10.

Authors:  Jason S Stumhofer; Jonathan S Silver; Arian Laurence; Paige M Porrett; Tajie H Harris; Laurence A Turka; Matthias Ernst; Christiaan J M Saris; John J O'Shea; Christopher A Hunter
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

9.  Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.

Authors:  David Bending; Hugo De la Peña; Marc Veldhoen; Jenny M Phillips; Catherine Uyttenhove; Brigitta Stockinger; Anne Cooke
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

10.  IL-23 promotes maintenance but not commitment to the Th17 lineage.

Authors:  Gretta L Stritesky; Norman Yeh; Mark H Kaplan
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

View more
  2 in total

1.  The novel small-molecule TPN10456 inhibits Th17 cell differentiation and protects against experimental autoimmune encephalomyelitis.

Authors:  Cuixia Yang; Jie Lv; Xiangrui Jiang; Zhenglong Xiang; Ran Gong; Jiahua Xing; Guangyu Liu; Ling Xie; Kandireya Saimaier; Yan Zhang; Junjian Wang; Hu Shen; Juping Pan; Jingshan Shen; Changsheng Du
Journal:  Cell Mol Immunol       Date:  2020-10-27       Impact factor: 11.530

Review 2.  Changes in Deoxyribonucleic Acid Methylation Contribute to the Pathophysiology of Multiple Sclerosis.

Authors:  Naiara Celarain; Jordi Tomas-Roig
Journal:  Front Genet       Date:  2019-11-12       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.